T-cell mediated delayed type hypersensitivity conditions in mammalian patients are alleviated by a process in which an aliquot of blood is withdrawn from the patient, treated extracorporeally with a combination of UV radiation and an oxidative environment, such as an oxygen/ozone gas mixture bubbled through the aliquot, and then re-injected into the patient.
申请公布号
WO0062788(A9)
申请公布日期
2001.10.25
申请号
WO2000CA00433
申请日期
2000.04.19
申请人
VASOGEN IRELAND LIMITED;SAUDER, DANIEL;MANDEL, ARKADY;BOLTON, ANTHONY, E.